XML 19 R8.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Inventory | 3 Months Ended
--- | ---
Mar. 31, 2017
Inventory Disclosure [Abstract] |
Inventory | Note 3 – Inventory Inventory consists of finished goods, components and raw materials. The Company’s inventory is stated at the lower of cost (FIFO cost basis) or market. The carrying value of inventory consisted of the following:
|  | March 31, 2017 |  |  | December 31, 2016 |
Finished goods |  | $ | 265,710 |  |  | $ | 474,420 |
Components |  |  | 334,475 |  |  |  | 431,241 |
Inventory in transit |  |  | 47,822 |  |  |  | 104,500 |
Raw materials |  |  | 92,617 |  |  |  | 92,616 |
Total inventory |  | $ | 740,624 |  |  | $ | 1,102,777 |
On January 22, 2015, inventory was pledged to Knight Therapeutics under the Loan Agreement (see note 10).

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -URI http://asc.fasb.org/topic&trid=2126998 + Details
Name: | us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration